{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T21:23:43Z","timestamp":1789421023996,"version":"build-2803163510"},"reference-count":44,"publisher":"Pharmaceutical Society of Japan","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2025,11,20]]},"DOI":"10.1248\/bpb.b25-00545","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T22:06:06Z","timestamp":1763589966000},"page":"1784-1793","source":"Crossref","is-referenced-by-count":1,"title":["Grandifloridin D: A Potent Antiausterity Agent Targeting Pancreatic Cancer Cells &lt;i&gt;via&lt;\/i&gt; Akt\/mTOR and Autophagy Inhibition"],"prefix":"10.1248","volume":"48","author":[{"given":"Hung Hong","family":"Nguyen","sequence":"first","affiliation":[{"name":"Natural Drug Discovery Laboratory, Institute of Natural Medicine, University of Toyama, 2630 Sugitani, Toyama 930\u20130194, Japan"},{"name":"Department of Surgery and Science, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama 930\u20130194, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juthamart","family":"Maneenet","sequence":"additional","affiliation":[{"name":"Natural Drug Discovery Laboratory, Institute of Natural Medicine, University of Toyama, 2630 Sugitani, Toyama 930\u20130194, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsutomu","family":"Fujii","sequence":"additional","affiliation":[{"name":"Department of Surgery and Science, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama 930\u20130194, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Caggiano","sequence":"additional","affiliation":[{"name":"Department of Life Sciences, University of Bath, Bath BA2 7AY, U.K"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon E.","family":"Lewis","sequence":"additional","affiliation":[{"name":"Department of Chemistry, University of Bath, Bath BA2 7AY, U.K"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suresh","family":"Awale","sequence":"additional","affiliation":[{"name":"Natural Drug Discovery Laboratory, Institute of Natural Medicine, University of Toyama, 2630 Sugitani, Toyama 930\u20130194, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"163","reference":[{"key":"1","unstructured":"1) Foundation for Promotion of Cancer Research. \u201cCancer statistics in Japan\u20132022\u201d: &lt;https:\/\/ganjoho.jp\/public\/qa_links\/report\/statistics\/pdf\/cancer_statistics_2022_fig_E.pdf&gt;, accessed 17 April 2025."},{"key":"2","unstructured":"2) Cancer Research UK. \u201cPancreatic cancer statistics\u20132014\u201d: &lt;https:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/statistics-by-cancer-type\/pancreatic-cancer&gt;, accessed 17 April 2025."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Khalaf N, El-Serag HB, Abrams HR, Thrift AP. Burden of pancreatic cancer: from epidemiology to practice. <i>Clin. Gastroenterol. Hepatol.<\/i>, <b>19<\/b>, 876\u2013884 (2021).","DOI":"10.1016\/j.cgh.2020.02.054"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Sun S, Kim MJ, Omar AM, Phan ND, Awale S. (+)-Panduratin A induces PANC-1 human pancreatic cancer cell death preferentially under nutrient starvation by inhibiting PI3K\/Akt\/mTOR\/autophagy signaling pathway. <i>Phytomed. Plus.<\/i>, <b>1<\/b>, 100101 (2021).","DOI":"10.1016\/j.phyplu.2021.100101"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Sun S, Kim MJ, Omar AM, Duy Phan N, Aoike M, Awale S. GDP induces PANC-1 human pancreatic cancer cell death preferentially under nutrient starvation by inhibiting PI3K\/Akt\/mTOR\/autophagy signaling pathway. <i>Chem. Biodivers.<\/i>, <b>18<\/b>, e2100389 (2021).","DOI":"10.1002\/cbdv.202100389"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Koltai T, Reshkin SJ, Carvalho MA, Di Molfetta D, Greco MR, Alfarouk KO, Cardone RA. Resistance to gemcitabine in pancreatic ductal adenocarcinoma: a physiopathologic and pharmacologic review. <i>Cancers<\/i>, <b>14<\/b>, 2486 (2022).","DOI":"10.3390\/cancers14102486"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Tomohara K, Maneenet J, Ohashi N, Nose T, Fujii R, Kim MJ, Sun S, Awale S. Ugi adducts as novel anti-austerity agents against PANC-1 human pancreatic cancer cell line: a rapid synthetic approach. <i>Biol. Pharm. Bull.<\/i>, <b>46<\/b>, 1412\u20131420 (2023).","DOI":"10.1248\/bpb.b23-00224"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Awale S, Lu J, Kalauni SK, Kurashima Y, Tezuka Y, Kadota S, Esumi H. Identification of arctigenin as an antitumor agent having the ability to eliminate the tolerance of cancer cells to nutrient starvation. <i>Cancer Res.<\/i>, <b>66<\/b>, 1751\u20131757 (2006).","DOI":"10.1158\/0008-5472.CAN-05-3143"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Awale S, Nakashima EMN, Kalauni SK, Tezuka Y, Kurashima Y, Lu J, Esumi H, Kadota S. Angelmarin, a novel anti-cancer agent able to eliminate the tolerance of cancer cells to nutrient starvation. <i>Bioorg. Med. Chem. Lett.<\/i>, <b>16<\/b>, 581\u2013583 (2006).","DOI":"10.1016\/j.bmcl.2005.10.046"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Ueda J, Athikomkulchai S, Miyatake R, Saiki I, Esumi H, Awale S. (+)-Grandifloracin, an antiausterity agent, induces autophagic PANC-1 pancreatic cancer cell death. <i>Drug Des. Devel. Ther.<\/i>, <b>8<\/b>, 39\u201347 (2013).","DOI":"10.2147\/DDDT.S52168"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Awale S, Dibwe DF, Balachandran C, Fayez S, Feineis D, Lombe BK, Bringmann G. Ancistrolikokine E<sub>3<\/sub>, a 5,8\u2032-coupled naphthylisoquinoline alkaloid, eliminates the tolerance of cancer cells to nutrition starvation by inhibition of the Akt\/mTOR\/autophagy signaling pathway. <i>J. Nat. Prod.<\/i>, <b>81<\/b>, 2282\u20132291 (2018).","DOI":"10.1021\/acs.jnatprod.8b00733"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Phan ND, Omar AM, Takahashi I, Baba H, Okumura T, Imura J, Okada T, Toyooka N, Fujii T, Awale S. Nicolaioidesin C: an antiausterity agent shows promising antitumor activity in a pancreatic cancer xenograft mouse model. <i>J. Nat. Prod.<\/i>, <b>86<\/b>, 1402\u20131410 (2023).","DOI":"10.1021\/acs.jnatprod.3c00019"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Awale S, Baba H, Phan ND, Kim MJ, Maneenet J, Sawaki K, Kanda M, Okumura T, Fujii T, Okada T, Maruyama T, Okada T, Toyooka N. Targeting pancreatic cancer with novel plumbagin derivatives: design, synthesis, molecular mechanism, <i>in vitro<\/i> and <i>in vivo<\/i> evaluation. <i>J. Med. Chem.<\/i>, <b>66<\/b>, 8054\u20138065 (2023).","DOI":"10.1021\/acs.jmedchem.3c00394"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Awale S, Maneenet J, Phan ND, Nguyen HH, Fujii T, Ihmels H, Soost D, Tajuddeen N, Feineis D, Bringmann G. Toyaburgine, a synthetic <i>N<\/i>-biphenyl-dihydroisoquinoline inspired by related <i>N,C<\/i>-coupled naphthylisoquinoline alkaloids, with high <i>in vivo<\/i> efficacy in preclinical pancreatic cancer models. <i>ACS Chem. Biol.<\/i>, <b>20<\/b>, 917\u2013929 (2025).","DOI":"10.1021\/acschembio.4c00870"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Ikeda M, Sato A, Mochizuki N, Toyosaki K, Miyoshi C, Fujioka R, Mitsunaga S, Ohno I, Hashimoto Y, Takahashi H, Hasegawa H, Nomura S, Takahashi R, Yomoda S, Tsuchihara K, Kishino S, Esumi H. Phase I trial of GBS-01 for advanced pancreatic cancer refractory to gemcitabine. <i>Cancer Sci.<\/i>, <b>107<\/b>, 1818\u20131824 (2016).","DOI":"10.1111\/cas.13086"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Awale S, Ueda J, Athikomkulchai S, Abdelhamed S, Yokoyama S, Saiki I, Miyatake R. Antiausterity agents from <i>Uvaria dac<\/i> and their preferential cytotoxic activity against human pancreatic cancer cell lines in a nutrient-deprived condition. <i>J. Nat. Prod.<\/i>, <b>75<\/b>, 1177\u20131183 (2012).","DOI":"10.1021\/np300295h"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Awale S, Tawila AM, Dibwe DF, Ueda J, Sun S, Athikomkulchai S, Balachandran C, Saiki I, Matsumoto K, Esumi H. Highly oxygenated antiausterity agents from the leaves of Uvaria dac. <i>Bioorg. Med. Chem. Lett.<\/i>, <b>27<\/b>, 1967\u20131971 (2017).","DOI":"10.1016\/j.bmcl.2017.03.021"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Yong-Hong L, Li-Zhen X, Shi-Lin Y, Jie D, Yong-Su Z, Min Z, Nan-Jun S. Three cyclohexene oxides from Uvaria grandiflora. <i>Phytochemistry<\/i>, <b>45<\/b>, 729\u2013732 (1997).","DOI":"10.1016\/S0031-9422(97)00026-5"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Palframan MJ, Kociok-K\u00f6hn G, Lewis SE. Total synthesis of (+)-grandifloracin by iron complexation of a microbial arene oxidation product. <i>Org. Lett.<\/i>, <b>13<\/b>, 3150\u20133153 (2011).","DOI":"10.1021\/ol201057r"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) D\u2019Arcy TD, Elsegood MRJ, Buckley BR. Organocatalytic enantioselective synthesis of bicyclo[2.2.2]octenones <i>via<\/i> oxaziridinium catalysed <i>ortho<\/i>-hydroxylative phenol dearomatization. <i>Angew. Chem. Int. Ed., Engl.<\/i>, <b>61<\/b>, e202205278 (2022).","DOI":"10.1002\/anie.202205278"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Shimizu EA, Cory B, Hoang J, Castro GG, Jung ME, Vosburg DA. Aqueous dearomatization\/Diels-Alder cascade to a grandifloracin precursor. <i>J. Chem. Educ.<\/i>, <b>96<\/b>, 998\u20131001 (2019).","DOI":"10.1021\/acs.jchemed.8b00857"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Bergner M, Duquette DC, Chio L, Stoltz BM. Exceedingly efficient synthesis of (\u00b1)-grandifloracin and acylated analogues. <i>Org. Lett.<\/i>, <b>17<\/b>, 3008\u20133010 (2015).","DOI":"10.1021\/acs.orglett.5b01292"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Dong S, Cahill KJ, Kang MI, Colburn NH, Henrich CJ, Wilson JA, Beutler JA, Johnson RP, Porco JA Jr. Microwave-based reaction screening: tandem retro-Diels-Alder\/Diels-Alder cycloadditions of <i>o<\/i>-quinol dimers. <i>J. Org. Chem.<\/i>, <b>76<\/b>, 8944\u20138954 (2011).","DOI":"10.1021\/jo201658y"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Lebrasseur N, Gagnepain J, Ozanne-Beaudenon A, L\u00e9ger JM, Quideau S. Efficient access to orthoquinols and their [4 + 2] cyclodimers <i>via<\/i> SIBX-mediated hydroxylative phenol dearomatization. <i>J. Org. Chem.<\/i>, <b>72<\/b>, 6280\u20136283 (2007).","DOI":"10.1021\/jo0708893"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Alexander BE, Sun S, Palframan MJ, Kociok-K\u00f6hn G, Dibwe DF, Watanabe S, Caggiano L, Awale S, Lewis SE. Sidechain diversification of grandifloracin allows identification of analogues with enhanced anti-austerity activity against human PANC-1 pancreatic cancer cells. <i>ChemMedChem<\/i>, <b>15<\/b>, 125\u2013135 (2020).","DOI":"10.1002\/cmdc.201900549"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Ali Khan M, Wood PJ, Lamb-Guhren NM, Caggiano L, Kociok-K\u00f6hn G, Tosh D, Lewis SE. The enone motif of (+)-grandifloracin is not essential for \u2018anti-austerity\u2019 antiproliferative activity. <i>Bioorg. Med. Chem. Lett.<\/i>, <b>24<\/b>, 2815\u20132819 (2014).","DOI":"10.1016\/j.bmcl.2014.04.111"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Deer EL, Gonzalez-Hernandez J, Coursen JD, Shea JE, Ngatia J, Scaife CL, Firpo MA, Mulvihill SJ. Phenotype and genotype of pancreatic cancer cell lines. <i>Pancreas<\/i>, <b>39<\/b>, 425\u2013435 (2010).","DOI":"10.1097\/MPA.0b013e3181c15963"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Gu X, Wei S, Lv X. Circulating tumor cells: from new biological insights to clinical practice. <i>Signal Transduct. Target. Ther.<\/i>, <b>9<\/b>, 226 (2024).","DOI":"10.1038\/s41392-024-01938-6"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Peng Y, Wang Y, Zhou C, Mei W, Zeng C. PI3K\/Akt\/mTOR pathway and its role in cancer therapeutics: are we making headway? <i>Front. Oncol.<\/i>, <b>12<\/b>, 819128 (2022).","DOI":"10.3389\/fonc.2022.819128"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Daga KR, Priyadarshani P, Larey AM, Rui K, Mortensen LJ, Marklein RA. Shape up before you ship out: morphology as a potential critical quality attribute for cellular therapies. <i>Curr. Opin. Biomed. Eng.<\/i>, <b>20<\/b>, 100352 (2021).","DOI":"10.1016\/j.cobme.2021.100352"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Liu Z, Chen J, Ren Y, Liu S, Ba Y, Zuo A, Luo P, Cheng Q, Xu H, Han X. Multi-stage mechanisms of tumor metastasis and therapeutic strategies. <i>Signal Transduct. Target. Ther.<\/i>, <b>9<\/b>, 270 (2024).","DOI":"10.1038\/s41392-024-01955-5"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Li Y, Liu F, Cai Q, Deng L, Ouyang Q, Zhang XHF, Zheng J. Invasion and metastasis in cancer: molecular insights and therapeutic targets. <i>Signal Transduct. Target. Ther.<\/i>, <b>10<\/b>, 57 (2025).","DOI":"10.1038\/s41392-025-02148-4"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Liu M, Yang J, Xu B, Zhang X. Tumor metastasis: mechanistic insights and therapeutic interventions. <i>MedComm<\/i>, <b>2<\/b>, 587\u2013617 (2021).","DOI":"10.1002\/mco2.100"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Sarantis P, Koustas E, Papadimitropoulou A, Papavassiliou AG, Karamouzis MV. Pancreatic ductal adenocarcinoma: treatment hurdles, tumor microenvironment and immunotherapy. <i>World J. Gastrointest. Oncol.<\/i>, <b>12<\/b>, 173\u2013181 (2020).","DOI":"10.4251\/wjgo.v12.i2.173"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Cordeiro S, Oliveira BB, Valente R, Ferreira D, Luz A, Baptista PV, Fernandes AR. Breaking the mold: 3D cell cultures reshaping the future of cancer research. <i>Front. Cell Dev. Biol.<\/i>, <b>12<\/b>, 1507388 (2024).","DOI":"10.3389\/fcell.2024.1507388"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Kpeglo D, Hughes MDG, Dougan L, Haddrick M, Knowles MA, Evans SD, Peyman SA. Modeling the mechanical stiffness of pancreatic ductal adenocarcinoma. <i>Matrix Biol. Plus<\/i>, <b>14<\/b>, 100109 (2022).","DOI":"10.1016\/j.mbplus.2022.100109"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Delle Cave D, Rizzo R, Sainz B Jr, Gigli G, del Mercato LL, Lonardo E. The revolutionary roads to study cell-cell interactions in 3D <i>in vitro<\/i> pancreatic cancer models. <i>Cancers<\/i>, <b>13<\/b>, 930 (2021).","DOI":"10.3390\/cancers13040930"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Longati P, Jia X, Eimer J, Wagman A, Witt MR, Rehnmark S, Verbeke C, Toftg\u00e5rd R, L\u00f6hr M, Heuchel RL. 3D pancreatic carcinoma spheroids induce a matrix-rich, chemoresistant phenotype offering a better model for drug testing. <i>BMC Cancer<\/i>, <b>13<\/b>, 95 (2013).","DOI":"10.1186\/1471-2407-13-95"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Luo W, Qiu J, Zheng L, Zhang T. Novel therapies targeting hypoxia mechanism to treat pancreatic cancer. <i>Chin. J. Cancer Res.<\/i>, <b>33<\/b>, 216\u2013231 (2021).","DOI":"10.21147\/j.issn.1000-9604.2021.02.09"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Li J, Chen X, Kang R, Zeh H, Klionsky DJ, Tang D. Regulation and function of autophagy in pancreatic cancer. <i>Autophagy<\/i>, <b>17<\/b>, 3275\u20133296 (2021).","DOI":"10.1080\/15548627.2020.1847462"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) Levy JMM, Towers CG, Thorburn A. Targeting autophagy in cancer. <i>Nat. Rev. Cancer.<\/i>, <b>17<\/b>, 528\u2013542 (2017).","DOI":"10.1038\/nrc.2017.53"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42) He C. Balancing nutrient and energy demand and supply <i>via<\/i> autophagy. <i>Curr. Biol.<\/i>, <b>32<\/b>, R684\u2013R696 (2022).","DOI":"10.1016\/j.cub.2022.04.071"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43) Grasso D, Renna FJ, Vaccaro MI. Initial steps in mammalian autophagosome biogenesis. <i>Front. Cell Dev. Biol.<\/i>, <b>6<\/b>, 146 (2018).","DOI":"10.3389\/fcell.2018.00146"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44) Hu C, Dadon T, Chenna V, Yabuuchi S, Bannerji R, Booher R, Strack P, Azad N, Nelkin BD, Maitra A. Combined inhibition of cyclin-dependent kinases (dinaciclib) and Akt (MK-2206) blocks pancreatic tumor growth and metastases in patient-derived xenograft models. <i>Mol. Cancer Ther.<\/i>, <b>14<\/b>, 1532\u20131539 (2015).","DOI":"10.1158\/1535-7163.MCT-15-0028"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/48\/11\/48_b25-00545\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T03:24:18Z","timestamp":1763781858000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/48\/11\/48_b25-00545\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,20]]},"references-count":44,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b25-00545","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,20]]},"article-number":"b25-00545"}}